Summary:
- Cellugy, a biotechnology startup based in Søborg, Denmark, secured €8.1M in funding from the European Union’s LIFE Programme to develop biobased solutions for the personal care sector.
- The company plans to use the funds to scale up operations, optimize processes, and validate commercial viability over a four-year period.
- Cellugy’s EcoFLEXY technology offers superior performance and functionality compared to traditional biobased ingredients, catering to cosmetics manufacturers’ sustainability demands without compromising product quality.
—
Article:
Cellugy Secures €8.1M Funding for Biobased Solutions in Personal Care Sector
Cellugy, a Danish biotechnology startup, recently announced that it has received €8.1 million in funding from the European Union’s LIFE Programme. This funding will support Cellugy’s mission to develop innovative biobased solutions to replace fossil-based materials in the personal care sector.
The grant from the LIFE Programme will enable Cellugy to accelerate critical scaling activities, optimize processes, and validate commercial potential over the next four years. Led by CEO Dr. Isabel Alvarez-Martos, Cellugy is focused on developing EcoFLEXY, a technology that offers enhanced performance and functionalities compared to traditional biobased ingredients like xanthan and cellulose gums.
EcoFLEXY’s biofabricated cellulose material not only delivers superior stability and compatibility but also addresses the handling challenges associated with plant-nanocellulose alternatives. This innovation is crucial for cosmetics manufacturers who are under increasing pressure to meet sustainability demands without compromising on product quality.
In conclusion, Cellugy’s successful funding round marks a significant milestone in the company’s journey towards revolutionizing the personal care sector with sustainable biobased solutions. With a strong focus on innovation and environmental responsibility, Cellugy is poised to make a lasting impact on the industry.
